Korean J Dermatol.  2014 Jun;52(6):394-401.

Immunohistochemical Double Staining of Ki-67/Melan-A in Melanocytic Nevi and Malignant Melanomas

Affiliations
  • 1Department of Dermatology, Yeung Nam University Hospital, Daegu, Korea. dhshin@med.yu.ac.kr
  • 2Department of Pathology, Yeung Nam University Hospital, Daegu, Korea.

Abstract

BACKGROUND
Melanomas need to be differentiated from benign melanocytic lesions during diagnosis. However, it is difficult to differentiate them using histopathology alone, since both neoplasms have broad morphological spectrums and subtle differentiating features.
OBJECTIVE
To evaluate the usefulness of Ki-67/Melan-A double staining for differentiating melanoma from benign melanocytic nevi.
METHODS
We selected 20 cases of intradermal nevi, 20 cases of compound nevi, 5 cases of dysplastic nevi, and 25 cases of melanoma from clinicopathologically proven cases reviewed by the Department of Dermatology at our medical center. Ki-67/Melan-A double staining was performed, and the Melan-A verified Ki-67 index (Ki-67-M index) and Ki-67 index were measured. The immunopositivity was measured in the deepest third of the lesions.
RESULTS
The Ki-67-M index of intradermal nevi, compound nevi, dysplastic nevi, and melanoma were 0.4+/-0.9%, 1.0+/-1.1%, 4.3+/-1.7%, and 24.1+/-10.9%, respectively. The best Ki-67/Melan-A cut-off point to distinguish melanomas from benign melanocytic nevi was 5%; the sensitivity and specificity were 100% and 97.7%, respectively. Immunopositivity in the deepest third of the intradermal nevi, compound nevi, and melanoma, were 10.5%, 20%, and 100%, respectively; the sensitivity and specificity for diagnosing melanoma were 100% and 84.6%, respectively. The sensitivity and specificity of combined Ki-67-M and immunopositivity in the deepest third for diagnosing melanoma were 100% and 97.7%, respectively.
CONCLUSION
The Ki-67-M index and immunopositivity in the deepest third of melanoma were significantly higher than that of benign melanocytic nevi. Therefore, Ki-67/Melan-A double staining is a potentially valuable diagnostic tool for differentiating melanoma from benign melanocytic nevi.

Keyword

Malignant melanoma; Benign melanocytic lesions; Ki-67/Melan-A double stain; Melanocytic nevus; Immunohistochemical double staining

MeSH Terms

Dermatology
Diagnosis
Dysplastic Nevus Syndrome
MART-1 Antigen
Melanoma*
Nevus
Nevus, Intradermal
Nevus, Pigmented*
Sensitivity and Specificity
MART-1 Antigen
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr